Nodality

company

About

Nodality develops biologically-informed clinical treatments for patients with cancer and autoimmune diseases.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$1.54M
Industries
Biotechnology,Clinical Trials,Health Care,Health Diagnostics
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

Nodality, Inc., a biotechnology company, discovers and develops personal diagnostics characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells from individual patients. The company focuses on hematological malignancies and autoimmune disorders. Nodality, Inc. was incorporated in 2003 and is based in San Francisco, California with an additional office in Franklin, Tennessee.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.54M
Nodality has raised a total of $1.54M in funding over 2 rounds. Their latest funding was raised on Aug 17, 2006 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 17, 2006 Series A $1.54M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Nodality is funded by 1 investors. TPG are the most recent investors.
Investor Name Lead Investor Funding Round
TPG Series A